A molecular profile in NSCLC patients: How? When? Why?
Introduction
Date
08 Oct 2016Session
A molecular profile in NSCLC patients: How? When? Why?Presenters
Fiona BlackhallAuthors
F. BlackhallAuthor affiliations
- Medical Oncology, The Christie NHS Foundation Trust, Manchester/GB
Resources
Login to access the resources on OncologyPRO.
If you do not have an ESMO account, please create one for free.
Resources from the same session
Organisation: Local, regional and national
Presenter: Fabrice Barlesi
Session: A molecular profile in NSCLC patients: How? When? Why?
Resources:
Slides
Getting the right drug to the right patient based upon molecular profiling
Presenter: Jean-Charles Soria
Session: A molecular profile in NSCLC patients: How? When? Why?
Resources:
Slides
Conclusions and clinical perspectives
Presenter: Fabrice Barlesi
Session: A molecular profile in NSCLC patients: How? When? Why?
Resources:
Slides
Clinical application of serial molecular biomarker monitoring
Presenter: Stephen Finn
Session: A molecular profile in NSCLC patients: How? When? Why?
Resources:
Slides